Concord Wealth Partners

Position in CRSP — CRISPR Therapeutics AG

CIK 1814214 ABINGDON, VA

Position in CRSP

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$599

+$23 QoQ

Shares Held

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#487

of 521 holders

Holding Since

Mar 2021

17 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Concord Wealth Partners holds $158,287 across 14 Biotechnology names. CRSP ranks #7 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KRYS	Krystal Biotech, Inc.	213	$79,165
2	ALNY	Alnylam Pharmaceuticals, Inc.	200	$60,206
3	AGIO	Agios Pharmaceuticals, Inc.	200	$7,422
4	HALO	Halozyme Therapeutics, Inc.	66	$5,165
5	TECH	BIO-TECHNE Corp	44	$3,108
6	FTRE	Fortrea Holdings Inc.	60	$1,044
7	CRSP	CRISPR Therapeutics AG This page	11	$599
8	MIRM	Mirum Pharmaceuticals, Inc.	5	$585

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$599	11	0.0%	Shares	Sole	2026-07-27
2025-12-31	$576	11	0.0%	Shares	Sole	2026-01-29
2025-06-30	$535	11	0.0%	Shares	Sole	2025-07-25
2024-09-30	$516	11	-45.0%	Shares	Sole	2024-10-24
2024-06-30	$1,080	20	-35.5%	Shares	Sole	2024-07-31
2024-03-31	$2,112	31	+55.0%	Shares	Sole	2024-04-30
2023-12-31	$1,252	20	-87.4%	Shares	Sole	2024-04-30
2023-09-30	$7,217	159	-44.2%	Shares	Sole	2024-04-30
2023-06-30	$15,999	285	+30.1%	Shares	Sole	2023-08-08
2023-03-31	$9,905	219	-83.3%	Shares	Sole	2023-04-26
2022-12-31	$53,454	1,315	-54.2%	Shares	Sole	2023-01-30
2022-06-30	$174,592	2,873	+141.8%	Shares	Sole	2022-08-04
2022-03-31	$74,570	1,188	+49.2%	Shares	Sole	2022-04-20
2021-12-31	$60,320	796	+277.3%	Shares	Sole	2022-01-21
2021-09-30	$23,617	211	-61.6%	Shares	Sole	2021-11-09
2021-06-30	$89,039	550	-4.3%	Shares	Sole	2021-07-29
2021-03-31	$70,063	575	—	Shares	Sole	2021-05-13
No filing history on record for this holder in this stock.